Healios secures £7m Series A funding from InHealth Ventures and AlbionVC to expand digital mental health services
The funding round was led by InHealth Ventures with backing from AlbionVC to scale digital therapy provision.
Healios provides online therapy and clinical assessment platforms for children and young people experiencing mental health and neurodiverse conditions. The company collaborates closely with NHS trusts to deliver tailored digital care pathways.
Healios has secured £7m in Series A funding to expand its digital mental health services and develop new assessment programmes. The investment was led by InHealth Ventures with participation from existing backer AlbionVC.
The company plans to direct the capital towards scaling its data science, artificial intelligence, and machine learning capabilities, alongside preparations for international expansion. Healios currently partners with a significant portion of NHS Mental Health Trusts to deliver remote clinical care and reduce lengthy waiting lists.
Richard Bradford of InHealth Ventures and Cat McDonald of AlbionVC will join the board following the transaction. The funding arrives amid surging demand for youth mental health provisions across the country.
From the founder
"The UK is facing a mental health crisis. Demand far outsrips supply and technology has a vital role to play in closing that gap. We’re immensely proud of the lives we’ve already changed through Healios. This funding will help us reach more families in need and enable us to develop further sector-leading interventions and therapies. By bringing together clinical experts and giving them the tools to reach their patients regardless of where they are, we are closing the access gap which has plagued mental health provision for far too long."
Rich Andrews
Founder and CEO at Healios
Investor perspective
"Healios is a standard bearer for healthcare innovation. They bring together clinical excellence with digital expertise, working in partnership with the NHS to address a critical, but complex area of care delivery. Healios’ work to date speaks for itself; their holistic approach to diagnosis and treatment has had a substantive impact on clinical outcomes and patient experience. We’re thrilled to have led this round and are excited to partner with the Healios team as they continue their pioneering and hugely important work."
Ben Evans
Managing Director, InHealth Ventures
Use of funds
- 01Continue product development
- 02Fund research and development
- 03Expand into international markets
